Research by Network

Show research belonging to this network:

P1078

Current Study

A Phase IV Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety (Hepatotoxicity) of Immediate (Antepartum-Initiated) vs. Deferred (Postpartum-Initiated) Isoniazid Preventive Therapy Among HIV-Infected Women in High TB incidence Set …

IMPAACT

More about this study »

P1115

Current Study

Very Early Intensive Treatment of HIV-Infected Infants  to Achieve HIV Remission: A Phase I/II Proof-of-Concept Study Sponsors: The National Institute of Allergy and Infectious Diseases (NIAD) The Eunice Kennedy Shriver National Institute of Child Heal …

IMPAACT

More about this study »

HPTN/IMPAACT 046

Completed Study

Phase III Trial to Determine the Efficacy and Safety of an Extended Regimen of Nevirapine in Infants Born to HIV Infected Women to Prevent Vertical HIV Transmission During Breastfeeding Sponsors: Division of AIDS, US National Institute of Allergy and I …

IMPAACT

More about this study »

PEPFAR 046

Completed Study

Integrating Family Planning into PMTCT: A Novel Approach in Zimbabwe (A Substudy of HPTN/IMPAACT 046) Sponsors: US National Institutes of Health (NIH) PEPFAR Protocol Summary: PEPFAR 046 sought to understand the feasibility and short-term effects of an …

IMPAACT

More about this study »

P1060

Completed Study

Phase II, Parallel, Randomized, Clinical Trials Comparing the Responses to Initiation of NNRTI-Based Versus PI-Based Antiretroviral Therapy in HIV-Infected Infants Who Have and Have Not Previously Received Single Dose Nevirapine for Prevention of Mothe …

IMPAACT

More about this study »

P1060

Completed Study

Phase II, Parallel, Randomized, Clinical Trials Comparing The Responses To Initiation of NNRTI-based Versus PI-Based Antiretroviral Therapy in HIV-Infected Infants Who Have And Have Not Previously Received Single Dose Nevirapine For Prevention of Mothe …

IMPAACT

More about this study »

P1070

Completed Study

Dose-Finding and Pharmacogenetic Study of Efavirenz in HIV-Infected and HIV/TB Co-Infected Infants and Children ≥ 3 Months to < 36 Months of Age Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID) The Eunice Kennedy Shriver Na …

IMPAACT

More about this study »

P1072

Completed Study

Safety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (ROTATEQTM) In HIV-Infected and Uninfected Children Born To HIV-Infected Mothers Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID) The Eunice Kennedy Shriver Na …

IMPAACT

More about this study »

P1073

Completed Study

Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children < 72 months of Age Sponsors: US National Institute of Allergy and Infectious Diseases …

IMPAACT

More about this study »

1077BF – PROMISE

Completed Study

Promoting Maternal and Infant Survival Everywhere (PROMISE) Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Protocol Summary: 1077BF …

IMPAACT

More about this study »

P1084s

Completed Study

Maternal and Infant Monitoring for Evidence of Toxicity Related to Tenofovir Exposure: The Bone and Kidney Health Substudy of the IMPAACT 1077 PROMSE Protocol Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID) The Eunice Kennedy …

IMPAACT

More about this study »

P1104s

Completed Study

Longitudinal Developmental and Neuropsychological Assessments of HIV infected Participants of P1060 and HIV Uninfected Sponsors: US National Institute of Allergy and Infectious Diseases (NIAD) The Eunice Kennedy Shriver National Institute of Child Heal …

IMPAACT

More about this study »